P175: Can time to surgery or size of tumor predict pathologic complete response (pCR) for early stage hormone receptor positive (HR+) (HER2-) breast cancer on a preoperative ablative S-PBI phase I trial

• DOI: 10.1016/j.breast.2025.104025
• Publication Date: 2025-03-10T11:06:01Z
• Authors: A. Rahimi; M. Leitch; B. Dogan; Y.-L. Liu; P. Alluri; M. Arbab; X. Li; D. Parsons; N. Wandrey; D. Farr; S. Seiler; N. Unni; A. Nguyen; R. Wooldridge; W. Lu; S. Stojadinovic; S. Bahrami; M. Stein; H. McArthur; S. Sahoo; R Timmerman
• Keywords: Ablative case